Doctor profile · Federal record
Dr. SHEFALI DHAM, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: ENDOCRINOLOGY) · Endocrinology, Diabetes & Metabolism Physician · PLEASANTON, CA
- NPI 1184808750
- Accepts Medicare
- 30 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5725 W LAS POSITAS BLVD STE 110
PLEASANTON, CA 945884016
(925) 416-6767 - Mailing address
-
480 SUTCLIFFE PL
WALNUT CREEK, CA 945983938
Credentials & registration
- NPI registered
- December 2007 — 19 yrs on file
- Profile last updated
- April 19, 2020
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State licenses (2)
- California #A113435 · New York #253758
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1184808750. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
7,867
Distinct HCPCS
9
Medicare allowed
$266,891
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 6,960 | 67 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 509 | 279 | $149 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 124 | 49 | $38 | |
96372 |
Injection of drug or substance under skin or into muscle | 116 | 67 | $17 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 54 | 51 | $107 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 41 | 41 | $190 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 29 | 26 | $210 | |
83036 |
Hemoglobin a1c level | 17 | 16 | $10 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 17 | 17 | $132 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 743. This provider delivers 11× the peer median.Open Payments
Industry payments received
All-time total
$131
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen Inc. | 1 | $131.10 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,416
Patients
431
Total drug cost
$734,769
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 291 | 84 | $5,984 |
| Metformin Hcl | Generic | 148 | 52 | $2,012 |
| Alendronate Sodium | Generic | 121 | 37 | $1,513 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 116 | 35 | $88,874 |
| Ozempic (Semaglutide) | Brand | 110 | 30 | $178,480 |
| Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 108 | 38 | $11,510 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 85 | 35 | $1,345 |
| Jardiance (Empagliflozin) | Brand | 76 | 24 | $99,400 |
| Trulicity (Dulaglutide) | Brand | 73 | 20 | $136,140 |
| Synthroid (Levothyroxine Sodium) | Brand | 71 | 19 | $8,085 |